The mTOR signaling-related gene, STK11, previously reported by our group as a poor prognostic factor for cervical cancer [15], was altered significantly more frequently in patients with NECC than in those with SCC (16.0% vs. 4.4%, p < 0.05, Figure 2A). This evidence concerns the gene MTOR and cervical carcinoma.